For comparison, a separate group received 2 doses of 212Pb-ADVC001 (500 kBq, 1 μg), with the first dose also leading to tumor recurrence in most animals 14 d after treatment, similar to 177Lu-PSMA-I&T (15 MBq, 1 μg). The gene discussed is FOLH1; the disease is neoplasm.